Cryptococcus neoformans, a yeastlike organism, is a significant cause of opportunistic infections with a marked predilection for the central nervous system (CNS) (20) . Cryptococcosis may occur as an asymptomatic pulmonary infection; however, immunocompromised hosts may present a fatal disseminated disease generally manifested as meningitis (33) . The disease is frequently observed in patients treated with corticosteroids or those with hematologic malignancies or AIDS. In AIDS, it is the fourth most common life-threatening disease (4, 9) .
Numerous in vitro studies have demonstrated that polymorphonuclear leukocytes (PMN), monocytes, and macrophages can ingest encapsulated cryptococci opsonized with either complement or anticryptococcal antibodies (6, 7, 19, 21, 22) . While PMN are clearly fungicidal, macrophages are less effective in killing C. neofornans in vitro (8, 27) , possibly because of the in vitro conditions used to generate activated macrophages (10, 14, 23) . In addition, it has been reported that natural killer cells can inhibit the growth of C. neofonnans in vitro (17, 28, 31) . Despite the importance of innate immunity, the capacity of the host to mount an adequate cell-mediated immune response also plays an important role in resistance to cryptococcosis (3, 25, 29) . The importance of such an immune response has been particularly evident in murine models (18) and in AIDS patients (4, 9) ; in these models and patients, helper T lymphocytes are affected.
We recently immortalized in vitro primary microglial cultures with a recombinant retrovirus carrying v-raf and v-myc oncogenes (1) . The continuous cell line BV-2 retains the morphological, phenotypic, and functional properties ascribed to primary microglia (12, 15) . Potent anti-Candida albicans activity is exhibited by BV-2 cells either in vitro or in vivo following intracerebral (i.c.) transfer into syngeneic mice which, in fact, resist a lethal local injection with C. albicans (2) . While the local mechanisms of host defense * Corresponding author. against C. albicans are still unclear, recent evidence has been provided that interleukin-1 and a low-virulence strain of C. albicans, known to induce a protective antifungal state when given systemically (36) , both act as potent immunomodulatory signals within the brain compartment (26) .
To gain more insight into the host-parasite relationship occurring at the cerebral level, we established an experimental model of i.c. infection with C. neoformans that evolved into lethal meningoencephalitis. We showed that upon opsonization, the in vivo pathogenic burden of the fungus was reduced, while its in vitro susceptibility to microglia-mediated antifungal effects was increased. An impairment of cerebral host defenses against C. neoformans was observed in mice exposed to chloroquine plus colchicine, agents known to block the functional properties of phagocytic cells (5, 11, 13) .
MATERIALS AND METHODS
Mice. Female CD-1 mice, 6 to 8 weeks of age, were obtained from Charles River Breeding Laboratories, Calco, Milan, Italy.
C. neoformans. An encapsulated strain of C. neoformans, ATCC 11240, was used. Stock cultures were maintained by biweekly passages on Sabouraud dextrose agar. The plates were kept at room temperature. Yeast cells were harvested from the agar plates, washed twice in saline by low-speed centrifugation (1,000 x g), and diluted to the appropriate concentration in RPMI 1640 medium or saline prior to being used in the in vitro or in vivo assays. C. neoformans was opsonized as follows. Microorganisms (2 x 108) were incubated for 20 min at 37°C in 200 ,ul of fresh mouse serum. The excess serum was removed, and appropriate dilutions were prepared in RPMI 1640 medium or saline for the assays.
Cell line. The BV-2 microglial cell line used in this study was obtained as previously described (1) . In brief, primary microglial cultures were infected with a v-raf and v-myc oncogene-carrying retrovirus and maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf Table 2 shows that the microorganisms gradually grew in the brain, which appeared heavily colonized 7 days after challenge. This phenomenon was followed by the subsequent appearance of CFU in the periphery. A histopathological analysis of brain sections from mice injected 15 days earlier with 103 yeast cells per mouse was performed. Figure 1A shows severe, diffuse meningitis with an extensive edematous reaction, characterized by numerous encapsulated yeast and mononuclear inflammatory cells (Fig. 1B) . As depicted in Fig. 1C , large necrotic paraventricular areas were also present and consisted mainly of encapsulated yeast cells, although infiltrates with a few inflammatory cells were also evident (Fig. 1D) .
To establish whether yeast opsonization could have any effect on cryptococcal pathogenicity, we incubated yeast cells in vitro with fresh mouse serum (20 min at 37°C) prior to i.c. challenge. Control mice received unopsonized C. neofonnans. We found that the MST of mice receiving opsonized yeast cells (103 or 1O4 yeast cells per mouse) was significantly longer than that of mice receiving unopsonized yeast cells (Fig. 2) . In contrast, C. neofonnans opsonization did not affect the MST of mice receiving larger inocula (105 and 106 yeast cells per mouse).
Since the administration of chloroquine plus colchicine is known to affect the phagocytic compartment (5, 11, 13), we In an attempt to dissect the events involved in resistance to i.c. infection with C. neoformans, we performed in vitro experiments using the recently established BV-2 microglial cell line (1). We evaluated the phagocytic properties of the microglial cells by incubating BV-2 cells with yeast cells that had or had not been opsonized. After 2 h, 51% of the BV-2 cells had ingested unopsonized yeast cells, whereas the percentage was 75% when opsonized C. neofornans microorganisms were used (Fig. 4A) . Moreover, the number of yeast cells ingested per BV-2 cell was augmented by opsonization, as indicated by the increased phagocytosis index (Fig. 4A) . Subsequently, BV-2 cell anticryptococcal ability was analyzed. 
DISCUSSION
In AIDS patients, C. neoformans is one of the most common causes of life-threatening infections (4) . Although the CNS represents a crucial target for this pathogen (21), scant information is available on the immune mechanisms involved in antifungal resistance within the CNS. Recently, Salkowski and Balish (35) demonstrated that immunocompetent and doubly (beige and athymic) immunodeficient mice differed in their susceptibilities to a systemic injection with C. neofonnans. Interestingly, only the former showed cellular infiltrates or abscess formation in or near the cryptococcal foci within the brain. Nevertheless, the dissemination and rate of growth of the fungus in the brain were similar in both genotypes. This result suggests that brain mechanisms that control the onset and development of a local infection(s) are very peculiar. The present study describes a murine model of i.c. infection with C. neofonnans. Following i.c. fungal inoculation, mice develop a lethal infection. The phenomenon is dose dependent and characterized by mas- In a previous report, we showed that i.c. administration of C. albicans results in a lethal infection, the severity being dependent on the inoculum size. In particular, doses as high as 106 C. albicans cells per mouse are needed to achieve 100% mortality (26) . Conversely, in this study, all mice died (Table 1) . We cannot ascribe such a difference to differences in virulence between the fungi, in that, when they are given systemically, opposite results are observed, i.e., mice are more susceptible to C. albicans than to C. neoformans (data not shown). Thus, we conclude that the cerebral district is more susceptible to C. neoformans than to C. albicans, and we hypothesize that in the brain compartment there are effector cells less active against the former fungus. Preliminary experiments support this hypothesis. In fact, using in vivo local transfer of microglial cells, we consistently failed to protect mice against i.c. infection with C. neofonnans (data not shown). Conversely, such a procedure is known to be highly effective against C. albicans infection (2) . Therefore, microglial cells are crucial elements of defense against C. albicans but are not as efficient against C. neofornans. Nevertheless, phagocytic cells play a defensive role against i.c. infection with C. neoformans, as shown by our studies of drug-treated mice. Previous reports demonstrated that in vivo administration of colchicine and/or chloroquine affects the phagocytic compartment by blocking phagocytosis, endocytosis, and secretory functions (5, 11, 13) . Furthermore, by monitoring local cellular responses to a penetrating brain injury, Giulian et al. (13) showed that the number of mononuclear phagocytes at injury sites is significantly reduced and that astrogliosis is inhibited in drugtreated animals compared with controls. Thus, a major effect of chloroquine and colchicine on myelomonocytic cells has been proven, although the possibility that they act on other cell types cannot be excluded. In this study, treatment with chloroquine plus colchicine significantly reduced the life spans of mice inoculated i.c. with C neoformans compared with those of non-drug-treated mice. When the size of the C. neoformans inoculum was reduced, the immunosuppressive effects of the drugs were more evident. This finding strongly supports the possibility that drug-susceptible, phagocytemediated mechanisms are important in resistance to C. neoformans within the CNS. Although it would be difficult to fully establish the extent of inhibition and the spectrum of action of chloroquine and colchicine at the cerebral level, this model may provide a useful tool for dissecting the anticryptococcal mechanisms involved in local resistance to i.c. fungal infections.
Clinical and experimental evidence indicates that initial pulmonary defenses against cryptococcosis involve T cells (18) and alveolar macrophages (24, 37) . Recent studies suggest that natural killer cells may contribute to natural immunity against fungi (16, 17, 30, 32) , while PMN, monocytes, and macrophages are likely crucial defenses against cryptococcemia. Killing of C. neofonnans by PMN and monocytes occurs via intra-and extracellular mechanisms, while opsonization is important in enhancing the efficacy of anticryptococcal effector cells (14, 19, 21) . In agreement with these reports, our in vivo experiments revealed augmented life spans in mice challenged i.c. with opsonized C. neoformans compared with mice receiving unopsonized fungi. Similar results were observed for drug-treated mice, suggesting that anticryptococcal elements other than phagocytic cells are effective against opsonized fungi. Some residual phagocyte-mediated activity, still present in drug-treated animals, may have accounted for the enhanced MST. In any case, our results imply that opsonization renders C neoformans more susceptible to fungicidal brain effector cells.
Our in vitro studies with the microglial cell line revealed that phagocytosis is increased when opsonized fungi are used, whereas antifungal activity occurs only against opsonized targets, unless long-term coincubation times are used. These data provide two major conclusions: (i) microglial cells are active anticryptococcal elements, in vitro and (ii) opsonization is also an important event in the fulfillment of microglia-mediated anticryptococcal activity in vitro.
Overall, our experimental model of i.c. infection may be a useful tool in further studies aimed at clarifying the cellular and molecular mechanisms controlling the CNS immune response during a C. neofornans infection.
